Daewoong to enter major vaccine business from Feb.

Published: 2006-01-26 06:56:00

Updated: 2006-01-26 06:56:00

Daewoong announced to engage in the vaccine business as a company major project by launching a PDT vaccine in a pre-filled syringe type, in coming February after establishing a specialized product line with the syringe type of all vaccine, a fixed dose and convenient administration.

The raw ma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK